Description: InterCure (dba Canndoc) is the leading cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to maintain its position as Israel’s leading cannabis company as well as to drive further growth through global expansion.
Home Page: www.intercure.co
INCR Technical Analysis
85 Medinat ha-Yehudim Street
Herzliya,
4676670
Israel
Phone:
972 7 7460 5012
Officers
| Name | Title |
|---|---|
| Mr. Alexander Rabinovitch | CEO & Director |
| Mr. Amos Cohen | Chief Financial Officer |
| Mr. Rami Levy | Chief Operating Officer of Canndoc |
| Mr. Omri Batzir | Corp. Controller |
| Advocate Asaf Ohayon | Co-Founder & Co-CEO of Cannolam Ltd. |
| Mr. Ori-Moni Mimon | Co-Founder & Co-CEO of Cannolam Ltd. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 6.9396 |
|---|---|
| Trailing PE: | 18.1818 |
| Price-to-Book MRQ: | 1.3914 |
| Price-to-Sales TTM: | 1.656 |
| IPO Date: | 2014-11-07 |
| Fiscal Year End: | December |
| Full Time Employees: | 350 |